ADHD News & Research
Vyvanse Generics Roll Out — And Disappoint
As the U.S. patent for Vyvanse expired August 2023, the FDA cleared 14 manufacturers to produce Vyvanse generics. It might take several months for a significant number of consumers to access these Vyvanse generics. At
09/01/2023
75 Comments
